Retour
Également cotée sous
BMXXY
OTC
Fourchette du Jour
102,25 €
115,00 €
Fourchette 52 Semaines
102,25 €
152,00 €
Volume
868
Moyenne 50J / 200J
117,87 €
/
130,64 €
Clôture Précédente
102,25 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 30,4 | 0,3 |
| P/B | 2,9 | 3,0 |
| ROE % | 9,6 | 3,7 |
| Net Margin % | 9,8 | 3,8 |
| Rev Growth 5Y % | 4,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
7,17 €
7,01 € – 7,49 €
|
5,37B | 1 |
| FY2029 |
6,61 €
6,46 € – 6,90 €
|
5,09B | 1 |
| FY2028 |
6,02 €
5,89 € – 6,29 €
|
4,79B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-27 | 2,50 € | 2,33 € | -6,8% |
| 2025-06-30 | 2,55 € | 1,59 € | -37,6% |
| 2024-12-31 | 2,23 € | 1,89 € | -15,2% |
| 2024-06-29 | N/A | 1,95 € | — |
| 2023-12-30 | N/A | 1,81 € | — |
| 2023-06-30 | N/A | 1,49 € | — |
| 2022-12-31 | N/A | 2,04 € | — |
| 2022-06-30 | N/A | 2,01 € | — |
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 4,77% annually over 5 years — modest growth
Debt/Equity of 0,11 — conservative balance sheet
Generating 452,83M in free cash flow
P/E of 30,38 — premium valuation
Cash machine — converts 113,96% of earnings into free cash flow
Capital efficient — spends only 8,24% of revenue on capex
Croissance
Revenue Growth (5Y)
4,77%
Revenue (1Y)2,22%
Earnings (1Y)-8,06%
FCF Growth (3Y)105,62%
Qualité
Return on Equity
9,57%
ROIC9,22%
Net Margin9,77%
Op. Margin13,79%
Sécurité
Debt / Equity
0,11
Current Ratio2,39
Interest Coverage0,00
Valorisation
P/E Ratio
30,38
Forward P/EN/A
P/B Ratio2,94
EV/EBITDA21,33
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,22% | Revenue Growth (3Y) | 5,22% |
| Earnings Growth (1Y) | -8,06% | Earnings Growth (3Y) | 5,41% |
| Revenue Growth (5Y) | 4,77% | Earnings Growth (5Y) | -9,83% |
| Profitability | |||
| Revenue (TTM) | 4,07B | Net Income (TTM) | 397,35M |
| ROE | 9,57% | ROA | 7,13% |
| Gross Margin | 52,63% | Operating Margin | 13,79% |
| Net Margin | 9,77% | Free Cash Flow (TTM) | 452,83M |
| ROIC | 9,22% | FCF Growth (3Y) | 105,62% |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 2,39 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 30,38 | Forward P/E | N/A |
| P/B Ratio | 2,94 | P/S Ratio | 2,97 |
| PEG Ratio | -3,99 | Forward PEG | N/A |
| EV/EBITDA | 21,33 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3,75% | ||
| Market Cap | 12,07B | Enterprise Value | 11,96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,07B | 3,98B | 3,67B | 3,59B | 3,38B |
| Net Income | 397,35M | 432,20M | 357,60M | 452,40M | 601,10M |
| EPS (Diluted) | 3,34 | 3,64 | 3,01 | 3,82 | 5,06 |
| Gross Profit | 2,14B | 2,22B | 2,06B | 2,01B | 2,00B |
| Operating Income | 560,99M | 588,80M | 439,00M | 587,20M | 784,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,57B | 5,77B | 5,26B | 5,19B | 4,62B |
| Total Liabilities | 1,47B | 1,56B | 1,51B | 1,54B | 1,44B |
| Shareholders' Equity | 4,10B | 4,20B | 3,75B | 3,60B | 3,12B |
| Total Debt | 461,23M | 490,70M | 518,80M | 505,40M | 462,50M |
| Cash & Equivalents | 569,59M | 449,80M | 352,40M | 552,60M | 803,50M |
| Current Assets | 2,54B | 2,50B | 2,21B | 2,22B | 2,21B |
| Current Liabilities | 1,06B | 1,13B | 1,09B | 1,13B | 955,90M |